Post-approval studies (Phase 4)Ended earlyNCT03756454
What this trial is testing
Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.
Who this might be right for
Clostridia Difficile ColitisClostridium; Sepsis
Michael E Villarreal, MD 5